Literature DB >> 19376312

Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis.

Hasan Jilaihawi1, Derek Chin, Mariuca Vasa-Nicotera, Mohamed Jeilan, Tomasz Spyt, G Andre Ng, Johan Bence, Elaine Logtens, Jan Kovac.   

Abstract

INTRODUCTION: Changes in atrioventricular (AV) conduction and need for permanent pacemaker (PPM) are a recognized complication after open aortic valve replacement. We hypothesized that the need for PPM after CoreValve (Corevalve Inc, Irvine, CA) can be predicted with a combination of baseline variables.
METHODS: In patients undergoing transcatheter aortic valve implantation, potential clinical, electrocardiographic and echocardiographic predictors of permanent pacing requirement were studied.
RESULTS: Between January 2007 and March 2008, 34 patients with severe symptomatic aortic stenosis were recruited in a single center. Mean age was 84.4 years (SD 5.4, range 71-93). Of 34 cases paced at baseline, 3 (8.8%) were excluded from this analysis, as was the single periprocedural mortality. Of the remaining 30, 10 underwent permanent pacemaker implantation during the same admission (33.3%). PPM was for prolonged high-grade AV block in 4 cases, episodic high-grade AV block in 5, and sinus node disease in 1. Need for pacemaker was correlated to left axis deviation at baseline (P = .004, r = 0.508) and left bundle-branch block with left axis deviation (P = .002, r = 0.548). It was related to diastolic interventricular septal dimension on transthoracic echocardiography >17 mm (P = .045, r = 0.39) and the baseline thickness of the native noncoronary cusp (P = .002, r = 0.655). A susceptibility model was generated, and if at least one of (1) left bundle-branch block with left axis deviation, (2) interventricular septal dimension >17 mm, or (3) noncoronary cusp thickness >8 mm was present, the likelihood of PPM could be predicted with 75% sensitivity and 100% specificity and a receiver operating characteristic curve area of 0.93 +/- 0.055 (P < .001).
CONCLUSIONS: After transcatheter aortic valve implantation with CoreValve, permanent pacing was performed in around a third of patients and we present preliminary concepts towards a predictive model for this phenomenon.

Entities:  

Mesh:

Year:  2009        PMID: 19376312     DOI: 10.1016/j.ahj.2009.02.016

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  31 in total

Review 1.  [Transcatheter aortic valve implantation : what do anesthetists need to know?].

Authors:  C Riediger; F Nietlispach; F Rüter; J Fassl
Journal:  Anaesthesist       Date:  2011-12       Impact factor: 1.041

2.  Comparison of multicenter registries and randomized control trials for transcatheter aortic valve replacement (TAVR).

Authors:  Shikhar Agarwal; E Murat Tuzcu; William Stewart; Navkaranbir Singh Bajaj; Lars G Svensson; Samir R Kapadia
Journal:  Indian Heart J       Date:  2013-07-10

3.  Impact of left ventricular conduction defect with or without need for permanent right ventricular pacing on functional and clinical recovery after TAVR.

Authors:  Marcel Weber; Eva Brüggemann; Robert Schueler; Diana Momcilovic; Jan-Malte Sinning; Alexander Ghanem; Nikos Werner; Eberhard Grube; Wolfgang Schiller; Fritz Mellert; Armin Welz; Georg Nickenig; Christoph Hammerstingl
Journal:  Clin Res Cardiol       Date:  2015-05-13       Impact factor: 5.460

4.  Subclavicular screwed wire transient pacing to increase safety of transcatheter aortic valve implantation with the CoreValve system.

Authors:  Thomas Cuisset; Jacques Quilici
Journal:  J Cardiol Cases       Date:  2011-04-06

5.  Transcatheter aortic valve replacement-state of the art and a glimpse to the future: 'the Tailored Approach'.

Authors:  Francesco Bedogni; Alessandro Frigiola; Marco Ranucci; Nedy Brambilla; Rocco Antonio Montone; Mauro Agnifili; Lorenzo Menicanti; Luca Testa
Journal:  Eur Heart J Suppl       Date:  2016-04-29       Impact factor: 1.803

Review 6.  TAVI 2012: state of the art.

Authors:  Jochen Reinöhl; Constantin von Zur Mühlen; Martin Moser; Stefan Sorg; Christoph Bode; Manfred Zehender
Journal:  J Thromb Thrombolysis       Date:  2013-05       Impact factor: 2.300

7.  Aortic stenosis in high-risk patients. Surgical therapy.

Authors:  T Walther; M Arsalan; J Blumenstein; A van Linden; J Kempfert
Journal:  Herz       Date:  2013-03       Impact factor: 1.443

8.  Permanent Pacemaker Implantation after TAVR - Predictors and Impact on Outcomes.

Authors:  Marcel Weber; Jan-Malte Sinning; Christoph Hammerstingl; Nikos Werner; Eberhard Grube; Georg Nickenig
Journal:  Interv Cardiol       Date:  2015-05

Review 9.  Clinical implications of conduction abnormalities and arrhythmias after transcatheter aortic valve implantation.

Authors:  Robert M A van der Boon; Patrick Houthuizen; Rutger-Jan Nuis; Nicolas M van Mieghem; Frits Prinzen; Peter P T de Jaegere
Journal:  Curr Cardiol Rep       Date:  2014-01       Impact factor: 2.931

10.  Emerging approaches of transcatheter valve repair/insertion.

Authors:  Maurizio Taramasso; Micaela Cioni; Andrea Giacomini; Iassen Michev; Cosmo Godino; Matteo Montorfano; Antonio Colombo; Ottavio Alfieri; Francesco Maisano
Journal:  Cardiol Res Pract       Date:  2010-07-25       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.